Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted September 20, 2010
Many Supplements Recalled for Hormone-Affecting Compounds
On September 20, 2010, the U.S. FDA posted a Safety Notice regarding the recalls of several products marketed as dietary supplements that contain aromatase inhibitors, commonly known as "ATD." Adverse events associated with the use of aromatase inhibitors could include the following: decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure, and liver dysfunction. Consumers with liver, kidney, adrenal, or prostate abnormalities are at higher risk for developing adverse events.